Meeting
2014 Palliative and Supportive Care in Oncology Symposium
Retrospective chart review of end-of-life (EOL) care in patients with metastatic lung cancer harboring EGFR mutations.
Authors
Jessica Ruth Bauman
Massachusetts General Hospital Cancer Center, Boston, MA
Jessica Ruth Bauman, Zofia Piotrowska, Emily Scribner, Brandon Temel, Rebecca Suk Heist, Lecia V. Sequist, Jennifer S. Temel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: End-of-Life Care, <span>Patient-Reported Outcomes</span>, and Survivorship
Track
Survivorship,Patient-Reported Outcomes: Mechanisms of Symptoms and Treatment Toxicities,Early Integration of Palliative Care in Cancer Care,Psycho-oncology,End-of-Life Care
Sub Track
End-of-Life Care
Citation
J Clin Oncol 32, 2014 (suppl 31; abstr 126)
DOI
10.1200/jco.2014.32.31_suppl.126
Abstract #
126
Poster Bd #
C3
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The association between systemic anticancer therapy (SACT) at the end of life (EOL) and acute care use among patients treated at oncology practices participating in the Oncology Care Model (OCM).
First Author: Maureen Canavan
Poster
2018 ASCO Quality Care Symposium
Trends in aggressive inpatient care at the end-of-life for stage IV lung cancer patients.
First Author: Chebli Mrad
Poster
2018 ASCO Quality Care Symposium
Advanced care planning and selection of therapy: Influence on hospitalization for patients with metastatic lung cancer.
First Author: Dana Angela Drzayich Jankus
Poster
2018 ASCO Annual Meeting
Tumor mutation burden and efficacy of targeted therapy in patients with EGFR mutant lung cancers.
First Author: Michael David Offin